# Biomarkers of Response to Taxotere in HRPC. ICORG 08-08, V2

> **NCT01160705** · — · COMPLETED · sponsor: **Cancer Trials Ireland** · enrollment: 73 (actual)

## Conditions studied

- Metastatic Cancer
- Prostate Cancer

## Interventions

- **DRUG:** docetaxel
- **GENETIC:** RNA analysis
- **GENETIC:** reverse transcriptase-polymerase chain reaction
- **OTHER:** circulating tumor cell analysis
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT01160705
- **Lead sponsor:** Cancer Trials Ireland
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2017-09-19
- **Final completion:** —
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2020-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01160705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01160705, "Biomarkers of Response to Taxotere in HRPC. ICORG 08-08, V2". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01160705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*